They have quite a bit of cash, 30 million to be exact. Appears they burn like 2-3mm a quarter as well.
$30M as of 9/30 and it looks like they burn closer to about $5M/quarter (at least as of last quarter). I know they disclosed before that they were looking for additional financing to help fund continuing trials of the lead drug, BL-1020. Presumably not because they are about out of cash but because they are fairly conservative and like to maintain a nice cash cushion.
News 
Market Data 
Discover 
